The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.

Dengue virus (DENV) is the most prevalent medically important mosquito-borne virus in the world. Upon DENV infection of a host cell, DENV nonstructural protein 1 (NS1) can be found intracellularly as a monomer, associated with the cell surface as a dimer, and secreted as a hexamer into the bloodstream. NS1 plays a variety of roles in the viral life cycle, particularly in RNA replication and immune evasion of the complement pathway. Over the past several years, key roles for NS1 in the pathogenesis of severe dengue disease have emerged, including direct action of the protein on the vascular endothelium and triggering release of vasoactive cytokines from immune cells, both of which result in endothelial hyperpermeability and vascular leak. Importantly, the adaptive immune response generates a robust response against NS1, and its potential contribution to dengue vaccines is also discussed.

[1]  Saira,et al.  Comparison of four serological methods and two RT-PCR assays for diagnosis and surveillance of Zika , 2018 .

[2]  P. Vidalain,et al.  A Global Interactome Map of the Dengue Virus NS1 Identifies Virus Restriction and Dependency Host Factors. , 2017, Cell reports.

[3]  M. Halloran,et al.  Antibody-dependent enhancement of severe dengue disease in humans , 2017, Science.

[4]  E. Harris,et al.  Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components , 2017, PLoS pathogens.

[5]  Shuying Wang,et al.  Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection , 2017, The Journal of Immunology.

[6]  C. King,et al.  Generation and Characterization of Antinonstructural Protein 1 Monoclonal Antibodies and Development of Diagnostics for Dengue Virus Serotype 2. , 2017, The American journal of tropical medicine and hygiene.

[7]  Daniel Olson,et al.  Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum , 2017, Science Translational Medicine.

[8]  Yee‐Shin Lin,et al.  Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection , 2017, Scientific Reports.

[9]  Lourdes Millán-Pérez Peña,et al.  IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever , 2017, Mediators of inflammation.

[10]  F. Rovida,et al.  Antibody-based assay discriminates Zika virus infection from other flaviviruses , 2017, Proceedings of the National Academy of Sciences.

[11]  Vianney Tricou,et al.  Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study. , 2017, The Lancet. Infectious diseases.

[12]  Karthik Gangavarapu,et al.  Genome sequencing reveals Zika virus diversity and spread in the Americas , 2017, bioRxiv.

[13]  T. Hertz,et al.  Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections , 2017, The Journal of Immunology.

[14]  K. Stacey,et al.  Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6 , 2017, Immunology and cell biology.

[15]  T. Yeo,et al.  Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity , 2017, Scientific Reports.

[16]  R. T. Sasmono,et al.  Association of Endothelial Glycocalyx and Tight and Adherens Junctions With Severity of Plasma Leakage in Dengue Infection , 2017, The Journal of infectious diseases.

[17]  Catharine I Paules,et al.  Yellow Fever - Once Again on the Radar Screen in the Americas. , 2017, The New England journal of medicine.

[18]  Yee‐Shin Lin,et al.  Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation , 2017, Laboratory Investigation.

[19]  S. Bhattacharyya,et al.  Platelet activation determines the severity of thrombocytopenia in dengue infection , 2017, Scientific Reports.

[20]  S. Mallal,et al.  Human CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity , 2016, Journal of Virology.

[21]  M. Diamond,et al.  Secreted NS1 Protects Dengue Virus from Mannose-Binding Lectin–Mediated Neutralization , 2016, The Journal of Immunology.

[22]  S. Halstead Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge , 2016, The American journal of tropical medicine and hygiene.

[23]  S. Kabra,et al.  Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India , 2016, Journal of Virology.

[24]  F. Scholle,et al.  Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells. , 2016, Virology.

[25]  G. Gao,et al.  Contribution of intertwined loop to membrane association revealed by Zika virus full‐length NS1 structure , 2016, The EMBO journal.

[26]  R. Mohana-Borges,et al.  Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins , 2016, Journal of Virology.

[27]  J. Stanaway,et al.  The global economic burden of dengue: a systematic analysis. , 2016, The Lancet. Infectious diseases.

[28]  E. Harris,et al.  Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability , 2016, PLoS pathogens.

[29]  Yee‐Shin Lin,et al.  Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy , 2016, PLoS neglected tropical diseases.

[30]  J. Wrammert,et al.  Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus , 2016, Proceedings of the National Academy of Sciences.

[31]  L. Kramer,et al.  Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement , 2016, PLoS pathogens.

[32]  Penghua Wang,et al.  Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes , 2016, Nature Microbiology.

[33]  Yi Shi,et al.  Zika virus NS1 structure reveals diversity of electrostatic surfaces among flaviviruses , 2016, Nature Structural &Molecular Biology.

[34]  G. Ogg,et al.  Dengue NS1 antigen contributes to disease severity by inducing interleukin (IL)‐10 by monocytes , 2015, Clinical and experimental immunology.

[35]  S. M. Costa,et al.  Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen , 2015, PLoS neglected tropical diseases.

[36]  R. Bartenschlager,et al.  Dengue Virus Non-structural Protein 1 Modulates Infectious Particle Production via Interaction with the Structural Proteins , 2015, PLoS pathogens.

[37]  Nicholas Jackson,et al.  Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. , 2015, The New England journal of medicine.

[38]  D. Hume,et al.  Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity , 2015, Science Translational Medicine.

[39]  Eva Harris,et al.  Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination , 2015, Science Translational Medicine.

[40]  S. A. de Oliveira,et al.  Circulating cytokines and chemokines associated with plasma leakage and hepatic dysfunction in Brazilian children with dengue fever. , 2015, Acta tropica.

[41]  Luis Carrasco,et al.  Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin , 2015, Viruses.

[42]  E. Pryzdial,et al.  Dengue virus binding and replication by platelets. , 2015, Blood.

[43]  J. Chu,et al.  Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection , 2015, PLoS pathogens.

[44]  A. S. St. John,et al.  Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors , 2015, eLife.

[45]  Dominic Waithe,et al.  Platelet Activating Factor Contributes to Vascular Leak in Acute Dengue Infection , 2015, PLoS neglected tropical diseases.

[46]  V. Volchkov,et al.  Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability , 2014, PLoS pathogens.

[47]  G. Ogg,et al.  Dengue NS1 antigen as a marker of severe clinical disease , 2014, BMC Infectious Diseases.

[48]  Bjoern Peters,et al.  The Human CD8+ T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes , 2014, Journal of Virology.

[49]  H. Margolis,et al.  Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody , 2014, PLoS Neglected Tropical Diseases.

[50]  R. Russell,et al.  The elusive function of the hepatitis C virus p7 protein , 2014, Virology.

[51]  S. Halstead,et al.  Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. , 2014, Human pathology.

[52]  R. Christofferson,et al.  Infection with dengue-2 virus alters proteins in naturally expectorated saliva of Aedes aegypti mosquitoes , 2014, Parasites & Vectors.

[53]  Yee‐Shin Lin,et al.  Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1 , 2014, PloS one.

[54]  A. Sette,et al.  T-Cell Immunity to Infection with Dengue Virus in Humans , 2014, Front. Immunol..

[55]  D. Fremont,et al.  Structural basis of Flavivirus NS1 assembly and antibody recognition , 2014, Proceedings of the National Academy of Sciences.

[56]  G. Skiniotis,et al.  Flavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune System , 2014, Science.

[57]  A. Adalja,et al.  An estimate of the global health care and lost productivity costs of dengue. , 2014, Vector borne and zoonotic diseases.

[58]  A. Falconar Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins , 2014, Archives of Virology.

[59]  Gathsaurie Neelika Malavige,et al.  T cell responses in dengue viral infections. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[60]  E. Fikrig,et al.  Mosquito Saliva Serine Protease Enhances Dissemination of Dengue Virus into the Mammalian Host , 2013, Journal of Virology.

[61]  Yee‐Shin Lin,et al.  Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and NF-κB Activation , 2013, The Journal of Immunology.

[62]  John A. Taylor,et al.  Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2 , 2013, Journal of Virology.

[63]  Gathsaurie Neelika Malavige,et al.  Serum IL-10 as a marker of severe dengue infection , 2013, BMC Infectious Diseases.

[64]  Juan Wang,et al.  Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice. , 2013, Molecular immunology.

[65]  M. Ng,et al.  Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage , 2013, eLife.

[66]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[67]  D. Fremont,et al.  Evidence for a Genetic and Physical Interaction between Nonstructural Proteins NS1 and NS4B That Modulates Replication of West Nile Virus , 2012, Journal of Virology.

[68]  B. Hankamer,et al.  Structure of the dengue virus glycoprotein non-structural protein 1 by electron microscopy and single-particle analysis. , 2012, The Journal of general virology.

[69]  G. Gervasi,et al.  Nonstructural protein NS1 immunodominant epitope detected specifically in dengue virus infected material by a SELDI‐TOF/MS based assay , 2012, Journal of medical virology.

[70]  Ronald J. Moore,et al.  Dengue Virus Infection Perturbs Lipid Homeostasis in Infected Mosquito Cells , 2012, PLoS pathogens.

[71]  Luís Carlos de Souza Ferreira,et al.  Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. , 2012, Vaccine.

[72]  John A. Taylor,et al.  Rotavirus NSP4 is secreted from infected cells as an oligomeric lipoprotein and binds to glycosaminoglycans on the surface of non-infected cells , 2011, Virology Journal.

[73]  Yee‐Shin Lin,et al.  Dengue Virus-Induced Autoantibodies Bind to Plasminogen and Enhance Its Activation , 2011, The Journal of Immunology.

[74]  B. Guy,et al.  From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. , 2011, Vaccine.

[75]  Cameron P. Simmons,et al.  Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with Dengue , 2011, PLoS neglected tropical diseases.

[76]  J. Farrar,et al.  Dextran Fractional Clearance Studies in Acute Dengue Infection , 2011, PLoS neglected tropical diseases.

[77]  M. Diamond,et al.  Binding of Flavivirus Nonstructural Protein NS1 to C4b Binding Protein Modulates Complement Activation , 2011, The Journal of Immunology.

[78]  A. Falconar,et al.  The NS1 Glycoprotein Can Generate Dramatic Antibody-Enhanced Dengue Viral Replication in Normal Out-Bred Mice Resulting in Lethal Multi-Organ Disease , 2011, PloS one.

[79]  S. Sekaran,et al.  The Diagnostic Sensitivity of Dengue Rapid Test Assays Is Significantly Enhanced by Using a Combined Antigen and Antibody Testing Approach , 2011, PLoS neglected tropical diseases.

[80]  M. Diamond,et al.  N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. , 2011, Virology.

[81]  A. Rothman,et al.  Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. , 2011, The Journal of infectious diseases.

[82]  Yee‐Shin Lin,et al.  Molecular mimicry between virus and host and its implications for dengue disease pathogenesis , 2011, Experimental biology and medicine.

[83]  J. d'Alayer,et al.  Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein , 2011, Proceedings of the National Academy of Sciences.

[84]  K. Ikuta,et al.  Highly conserved region 141‒168 of the NS1 protein is a new common epitope region of dengue virus. , 2011, Japanese journal of infectious diseases.

[85]  J. Ousingsawat,et al.  Rotavirus toxin NSP4 induces diarrhea by activation of TMEM16A and inhibition of Na+ absorption , 2011, Pflügers Archiv - European Journal of Physiology.

[86]  J. Farrar,et al.  Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status , 2011, The Journal of infectious diseases.

[87]  T. Gonda,et al.  PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models , 2011, British Journal of Cancer.

[88]  S. Yuan,et al.  Regulation of Endothelial Barrier Function , 2011 .

[89]  F. Zunino,et al.  SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis , 2011, Clinical Cancer Research.

[90]  I. Liu,et al.  Molecular Mimicry of Human Endothelial Cell Antigen by Autoantibodies to Nonstructural Protein 1 of Dengue Virus* , 2011, The Journal of Biological Chemistry.

[91]  N. Heaton,et al.  Dengue virus-induced autophagy regulates lipid metabolism. , 2010, Cell host & microbe.

[92]  C. Chipot,et al.  NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus* , 2010, The Journal of Biological Chemistry.

[93]  M. Diamond,et al.  Antagonism of the complement component C4 by flavivirus nonstructural protein NS1 , 2010, The Journal of experimental medicine.

[94]  Yue Chen,et al.  Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1. , 2010, Virology.

[95]  Tyler R. Prestwood,et al.  Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. , 2010, Cell host & microbe.

[96]  M. Diamond,et al.  Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification , 2010, PLoS pathogens.

[97]  B. Wills,et al.  Systemic vascular leakage associated with dengue infections - the clinical perspective. , 2010, Current topics in microbiology and immunology.

[98]  Yee‐Shin Lin,et al.  Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. , 2009, Molecular immunology.

[99]  U. Braga-Neto,et al.  Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity , 2009, PloS one.

[100]  R. Dwek,et al.  The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy , 2009, Proceedings of the National Academy of Sciences.

[101]  Yee‐Shin Lin,et al.  Deletion of the C-Terminal Region of Dengue Virus Nonstructural Protein 1 (NS1) Abolishes Anti-NS1-Mediated Platelet Dysfunction and Bleeding Tendency1 , 2009, The Journal of Immunology.

[102]  Ralf Bartenschlager,et al.  Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites , 2009, Cell Host & Microbe.

[103]  S. Kashiwagi,et al.  Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[104]  T. Kinoshita,et al.  Association of dengue virus NS1 protein with lipid rafts. , 2008, The Journal of general virology.

[105]  Yee‐Shin Lin,et al.  Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model , 2008, Laboratory Investigation.

[106]  R. Lanciotti,et al.  Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.

[107]  E. Harris,et al.  Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. , 2008, Virology.

[108]  S. Higgs,et al.  The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[109]  Yee‐Shin Lin,et al.  C-terminal region of dengue virus nonstructural protein 1 is involved in endothelial cell cross-reactivity via molecular mimicry , 2008 .

[110]  T. Solomon,et al.  Pathogenic flaviviruses , 2008, The Lancet.

[111]  C. King,et al.  Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in mice , 2007, Journal of thrombosis and haemostasis : JTH.

[112]  M. Diamond,et al.  Secreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E , 2007, PLoS pathogens.

[113]  Sheldon Weinbaum,et al.  The structure and function of the endothelial glycocalyx layer. , 2007, Annual review of biomedical engineering.

[114]  E. Harris,et al.  Dengue virus infects macrophages and dendritic cells in a mouse model of infection. , 2007, The Journal of infectious diseases.

[115]  Dick W. Slaaf,et al.  The endothelial glycocalyx: composition, functions, and visualization , 2007, Pflügers Archiv - European Journal of Physiology.

[116]  M. Guzmán,et al.  Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever‐dengue shock syndrome (DHF/DSS) , 2007, Immunology and cell biology.

[117]  S. Burgess,et al.  Evidence for the Formation of a Heptameric Ion Channel Complex by the Hepatitis C Virus P7 Protein in Vitro* , 2006, Journal of Biological Chemistry.

[118]  H. Schnittler,et al.  Structure‐Function Analysis of the Soluble Glycoprotein, sGP, of Ebola Virus , 2006, Chembiochem : a European journal of chemical biology.

[119]  R. Césaire,et al.  Evaluation of an Enzyme Immunoassay for Detection of Dengue Virus NS1 Antigen in Human Serum , 2006, Clinical and Vaccine Immunology.

[120]  K. Yuen,et al.  Serotype 1-Specific Monoclonal Antibody-Based Antigen Capture Immunoassay for Detection of Circulating Nonstructural Protein NS1: Implications for Early Diagnosis and Serotyping of Dengue Virus Infections , 2006, Journal of Clinical Microbiology.

[121]  M. Blettner,et al.  Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. , 2006, The Journal of infectious diseases.

[122]  Trai-Ming Yeh,et al.  Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. , 2006, The American journal of tropical medicine and hygiene.

[123]  A. Malik,et al.  Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.

[124]  Yee‐Shin Lin,et al.  Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 11 , 2005, The Journal of Immunology.

[125]  M. Miles,et al.  Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein , 2005, Archives of Virology.

[126]  M. Crabtree,et al.  Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: Construction and characterization of mutant viruses , 2005, Archives of Virology.

[127]  N. M. Dung,et al.  Size and charge characteristics of the protein leak in dengue shock syndrome. , 2004, The Journal of infectious diseases.

[128]  V. Volchkov,et al.  Ectodomain shedding of the glycoprotein GP of Ebola virus , 2004, The EMBO journal.

[129]  Elisabetta Dejana,et al.  Endothelial cell–cell junctions: happy together , 2004, Nature Reviews Molecular Cell Biology.

[130]  J. V. D. van der Meer,et al.  Cytokine patterns during dengue shock syndrome. , 2003, European cytokine network.

[131]  Yee‐Shin Lin,et al.  Antibodies from dengue patient sera cross‐react with endothelial cells and induce damage , 2003, Journal of medical virology.

[132]  A. Sanchez,et al.  Covalent Modifications of the Ebola Virus Glycoprotein , 2002, Journal of Virology.

[133]  A. Nisalak,et al.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, The Journal of infectious diseases.

[134]  Yee‐Shin Lin,et al.  Endothelial Cell Apoptosis Induced by Antibodies Against Dengue Virus Nonstructural Protein 1 Via Production of Nitric Oxide , 2002, The Journal of Immunology.

[135]  Robert Anderson,et al.  Dengue Virus Selectively Induces Human Mast Cell Chemokine Production , 2002, Journal of Virology.

[136]  Ting-Hsiang Lin,et al.  Potential Application of Nonstructural Protein NS1 Serotype-Specific Immunoglobulin G Enzyme-Linked Immunosorbent Assay in the Seroepidemiologic Study of Dengue Virus Infection: Correlation of Results with Those of the Plaque Reduction Neutralization Test , 2002, Journal of Clinical Microbiology.

[137]  Susana Vázquez,et al.  Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. , 2002, Revista panamericana de salud publica = Pan American journal of public health.

[138]  V. Deubel,et al.  Enzyme-Linked Immunosorbent Assay Specific to Dengue Virus Type 1 Nonstructural Protein NS1 Reveals Circulation of the Antigen in the Blood during the Acute Phase of Disease in Patients Experiencing Primary or Secondary Infections , 2002, Journal of Clinical Microbiology.

[139]  S. Dudek,et al.  Cytoskeletal regulation of pulmonary vascular permeability. , 2001, Journal of applied physiology.

[140]  Shoichiro Tsukita,et al.  Multifunctional strands in tight junctions , 2001, Nature Reviews Molecular Cell Biology.

[141]  E. Azeredo,et al.  Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. , 2001, Immunobiology.

[142]  Ting-Hsiang Lin,et al.  Dengue NS1‐specific antibody responses: Isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever , 2000, Journal of medical virology.

[143]  M. Guzmán,et al.  Human Dengue Antibodies against Structural and Nonstructural Proteins , 2000, Clinical Diagnostic Laboratory Immunology.

[144]  P. Young,et al.  An Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Levels of the Dengue Virus Protein NS1 in the Sera of Infected Patients , 2000, Journal of Clinical Microbiology.

[145]  J. Lepault,et al.  Dengue Virus Type 1 Nonstructural Glycoprotein NS1 Is Secreted from Mammalian Cells as a Soluble Hexamer in a Glycosylation-Dependent Fashion , 1999, Journal of Virology.

[146]  C. Rice,et al.  Genetic Interaction of Flavivirus Nonstructural Proteins NS1 and NS4A as a Determinant of Replicase Function , 1999, Journal of Virology.

[147]  Ying-Chang Wu,et al.  Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever , 1999, Journal of medical virology.

[148]  Processing of the Ebola virus glycoprotein. , 1999, Current topics in microbiology and immunology.

[149]  C. Rice,et al.  trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication , 1997, Journal of virology.

[150]  A. Falconar,et al.  The dengue virus nonstructural-1 protein (NS1) generatesantibodies to common epitopes on human blood clotting,integrin/adhesin proteins and binds to humanendothelial cells: potential implications in haemorrhagic fever pathogenesis , 1997, Archives of Virology.

[151]  C. Rice,et al.  Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. , 1996, Virology.

[152]  P. Young,et al.  Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. , 1996, Virology.

[153]  M. Sinniah,et al.  Augmented inflammatory cytokines in primary dengue infection progressing to shock. , 1995, Singapore medical journal.

[154]  P. J. Wright,et al.  Glycosylation mutants of dengue virus NS1 protein. , 1994, The Journal of general virology.

[155]  A. Nisalak,et al.  Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. , 1994, Archives of virology. Supplementum.

[156]  F. Ennis,et al.  Cytotoxic T lymphocytes in dengue virus infection. , 1994, Current topics in microbiology and immunology.

[157]  S. Sirinavin,et al.  Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. , 1991, The American journal of tropical medicine and hygiene.

[158]  G. Kuno,et al.  Study of anti‐dengue NS1 antibody by Western blot , 1990, Journal of medical virology.

[159]  J. Schlesinger,et al.  Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis , 1990, Journal of virology.

[160]  C. Rice,et al.  Flavivirus genome organization, expression, and replication. , 1990, Annual review of microbiology.

[161]  C. Mandl,et al.  Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. , 1989, Virology.

[162]  P. Mason Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells , 1989, Virology.

[163]  A. Nisalak,et al.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. , 1989, The American journal of tropical medicine and hygiene.

[164]  J. Schlesinger,et al.  Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. , 1988, The Journal of general virology.

[165]  J. Schlesinger,et al.  Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. , 1987, The Journal of general virology.

[166]  S. Halstead,et al.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. , 1984, American journal of epidemiology.

[167]  T. Chirachariyavej,et al.  Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. , 1980, The Southeast Asian journal of tropical medicine and public health.

[168]  S. Halstead In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.

[169]  SB Halstead,et al.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody , 1977, The Journal of experimental medicine.

[170]  M. Tuchinda,et al.  Histamine content in 24-hour urine in patients with dengue haemorrhagic fever. , 1977, The Southeast Asian journal of tropical medicine and public health.

[171]  S. Halstead,et al.  Human antibody to dengue soluble complement-fixing (SCF) antigens. , 1973, Journal of immunology.

[172]  D. L. Harris,et al.  Partial purification and characterization of a dengue virus soluble complement-fixing antigen. , 1970, Journal of immunology.

[173]  W. Brandt,et al.  Molecular size and charge relationships of the soluble complement-fixing antigens of dengue viruses. , 1970, Virology.

[174]  P. Moura,et al.  Detection of Circulant Tumor Necrosis Factor-α , Soluble Tumor Necrosis Factor p 75 and Interferon-γ in Brazilian Patients with Dengue Fever and Dengue Hemorrhagic Fever , 2022 .

[175]  A. Chakravarti,et al.  Circulating levels of tumour necrosis factor-α & interferon-γ in patients with dengue & dengue haemorrhagic fever during an outbreak , 2022 .